logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Gabriel Rinnerthaler

Medical University of Graz
H指数:26
被引数:2,722

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples

脑转移和原发乳腺癌样本的特性表征、免疫细胞分型及差异基因表达分析

Scientific Reports
IF3.9
2026-03-290
OAAI
Franz Josef Gassner; Gabriel Rinnerthaler; Vanessa Castagnaviz; Alejandra Gonzalez-Martinez; Thomas Parigger; Stephan Drothler; Richard Greil; Roland Geisberger; Theo F. J. Kraus; Alexander Romagna; Christoph Schwartz; Barbara Ladisich; Karl Sotlar; Cornelia Hauser-Kronberger; Beate Alinger-Scharinger; Markus Steiner; Nadja Zaborsky; Simon Peter Gampenrieder
Different types of electrostimulation target specific impaired sensory and motor functions in chemotherapy-induced peripheral neuropathy: a secondary analysis of a controlled trial

不同类型的电刺激针对化疗诱导的周围神经病变中的特定受损感觉和运动功能：一项对照试验的二次分析

Frontiers in Neurology
IF2.8
2026-03-040
OAAI
FR Florian Rieder †; RS Robert Sassmann; YT Yvonne Theres Kienberger; VC Vanessa Castagnaviz; DS Dagmar Schaffler-Schaden; TJ Tim Johansson; GR Gabriel Rinnerthaler; MF Maria Flamm; RG Richard Greil; CS Christoph Schulze; SP Simon Peter Gampenrieder
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34

ABCSG试验34中乳腺癌患者诊断性核心活检样本中的ESR1、PGR、ERBB2和MKi67 mRNA表达

The Breast
IF0
2025-10-300
OAAI
Stephanie Kacerovsky-Strobl; Christine Deutschmann; Dominik Hlauschek; Zsuzsanna Bago-Horvath; Christian F. Singer; Rupert Bartsch; Richard Greil; Karl Sotlar; Gabriel Rinnerthaler; Edgar Petru; Sigurd F. Lax; Daniel Egle; Angelika Pichler; Koppány Bodó; Andreas L. Petzer; Farid Moinfar; Jodi Weidler; Michael Bates; Peter Dubsky; Michael Gnant; Martin Filipits
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)

帕博西利联合辅助内分泌疗法在早期乳腺癌中的应用：全球多中心、开放标签、随机III期PALLAS试验（ABCSG-42/AFT-05/PrE0109/BIG-14-13）五年随访分析

Annals of Oncology
IF65.4
2025-10-170
OAAI
E.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2− breast cancer: insights and implications

单基因测序与基因panel测序在晚期HR+/HER2-乳腺癌中的临床影响：见解与启示

npj Breast Cancer
IF7.6
2025-08-070
OAAI
Eva Valentina Klocker; Nina Dobrić; Ricarda Graf; Christine Beichler; Dominik Hlauschek; Christoph Suppan; Lara Pancheri; Daniel Egle; Carmen Albertini; Rupert Bartsch; Angelika Martina Starzer; Philipp Jakob Jost; Gabriel Rinnerthaler; Ellen Heitzer; Nadia Dandachi; Marija Balic
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

新辅助阿替利珠单抗联合双HER2阻断加表柔比星方案治疗早期HER2阳性乳腺癌女性：随机Ⅱ期ABCSG-52/ATHENE试验

NATURE CANCER
IF28.5
2025-01-161
OA
Rinnerthaler, Gabriel; Bartsch, Rupert; Schmitt, Clemens A.; Petzer, Andreas; Petru, Edgar; Denison, Ursula; Singer, Christian F.; Bjelic-Radisic, Vesna; Gampenrieder, Simon Peter; Knauer, Michael; Sotlar, Karl; Brunner, Christine; Posch, Florian; Hlauschek, Dominik; Soelkner, Lidija; Bago-Horvath, Zsuzsanna; Filipits, Martin; Gili, Manuela; Ritter, Magdalena; Wieser, Verena; Albertini, Carmen; Zaborsky, Nadja; Weiss, Lukas; Marhold, Maximilian; Schneeweiss, Bruno; Pusch, Renate; Gnant, Michael; Greil, Richard
Change of first-line treatment pattern in metastatic luminal breast cancer: Results from the Austrian AGMT_MBC-Registry
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Rinnerthaler, Gabriel; Gampenrieder, Simon; Pichler, Angelika; Herz, Walter; Petzer, Andreas; Pusch, Renate; Balic, Marija; Suppan, Christoph; Heibl, Sonja; Scagnetti, Lukas; Sandholzer, Margit; Schmitt, Clemens; Zabernigg, August; Egle, Daniel; Pichler, Petra; Hager, Christopher; Roitner, Florian; Andel, Johannes; Strasser-Weippl, Kathrin; Bartsch, Rupert; Hubalek, Michael; Knauer, Michael; Singer, Christian F.; Greil, Richard
Pathological response according to early metabolic remission in an interim FDG-PET scan and to tumor infiltrating lymphocytes - A secondary analysis of the phase II trial ABCSG 52/ATHENE investigating atezolizumab in early HER2+BC
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Rinnerthaler, Gabriel; Egle, Daniel; Bartsch, Rupert; Schmitt, Clemens; Petzer, Andreas; Balic, Marija; Petru, Edgar; Denison, Ursula; Singer, Christian F.; Bjelic-Radisic, Vesna; Gampenrieder, Simon; Knauer, Michael; Sotlar, Karl; Brunner, Christine; Posch, Florian; Hlauschek, Dominik; Solkner, Lidija; Bago-Horvath, Zsuzsanna; Filipits, Martin; Gili, Manuela; Gnant, Michael; Greil, Richard
Drop-out rates from line to line of treatment in metastatic breast cancer (MBC): Results from the Austrian AGMT_MBC-Registry
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gampenrieder, Simon; Rinnerthaler, Gabriel; Pichler, Angelika; Herz, Walter; Petzer, Andreas; Dormann, Clemens; Balic, Marija; Suppan, Christoph; Heibl, Sonja; Scagnetti, Lukas; Sandholzer, Margit; Schmitt, Clemens; Zabernigg, August; Egle, Daniel; Pichler, Petra; Hager, Christopher; Roitner, Florian; Andel, Johannes; Strasser-Weippl, Kathrin; Bartsch, Rupert; Hubalek, Michael; Knauer, Michael; Singer, Christian F.; Greil, Richard
Prognosis and treatment landscape of HER2-positive metastatic breast cancer (MBC) before the availability of tucatinib and trastuzumab-deruxtecan: Results from the Austrian AGMT_MBC-Registry
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Gampenrieder, Simon P.; Rinnerthaler, Gabriel; Tinchon, Christoph; Petzer, Andreas; Balic, Marija; Heibl, Sonja; Sandholzer, Margit; Zabernigg, August F.; Egle, Daniel; Hager, Christopher; Pichler, Petra; Roitner, Florian; Andel, Johannes; Strasser-Weippl, Kathrin; Knauer, Michael; Hubalek, Michael; Singer, Christian F.; Greil, Richard
De-escalation of bone-targeted treatment: Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Beltran-Bless, Ana-Alicia; Clemons, Mark; Fesl, Christian; Hlauschek, Dominik; Soelkner, Lidija; Pond, Gregory R.; Vandermeer, Lisa; Greil, Richard; Balic, Marija; Bjelic-Radisic, Vesna; Singer, Christian F.; Steger, Guenther; Helfgott, Ruth; Egle, Daniel; Gampenrieder, Simon P.; Kacerovsky-Strobl, Stephanie; Suppan, Christoph; Ritter, Magdalena; Rinnerthaler, Gabriel; Pfeiler, Georg; Fohler, Hannes; Hilton, John; Gnant, Michael
Number of involved organs at baseline is prognostic for overall survival in patients with metastatic breast cancer: Results from the AGMT_MBC-Registry
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Rinnerthaler, Gabriel; Gampenrieder, Simon P.; Tinchon, Christoph; Petzer, Andreas; Balic, Marija; Heibl, Sonja; Sandholzer, Margit; Zabernigg, August F.; Egle, Daniel; Hager, Christopher; Pichler, Petra; Roitner, Florian; Andel, Johannes; Strasser-Weippl, Kathrin; Knauer, Michael; Hubalek, Michael; Singer, Christian F.
Interim analysis (n=200) from ELEANOR: a multinational, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer treated with extended adjuvant neratinib in the clinical routine
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Bartsch, Rupert; Harbeck, Nadia; Wrobel, Denise; Zaiss, Matthias; Terhaag, Jurgen; Guth, Dagmar; Distelrath, Andrea; Wuerstlein, Rachel; Zahn, Mark-Oliver; Luftner, Diana; Schwitter, Michael; Balic, Marija; Jackisch, Christian; Muller, Volkmar; Rinnerthaler, Gabriel; Schmidt, Marcus; Zaman, Khalil; Schinkothe, Timo; Resch, Anna; Breitenstein, Urs
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancerdresults from an international, multicenter analysis coordinated by the AGMT Study Group
ESMO OPEN
IF8.3
2023-02-0110
OAAI
Gampenrieder, S. P.; Dezentje, V.; Lambertini, M.; de Nonneville, A.; Marhold, M.; Le Du, F.; Salgado, A. Cortes; Costa, D. Alpuim; Batista, M. Vaz; Ruche, N. Chic; Tinchon, C.; Petzer, A.; Blondeaux, E.; Del Mastro, L.; Targato, G.; Bertucci, F.; Goncalves, A.; Viret, F.; Bartsch, R.; Mannsbart, C.; Deleuze, A.; Robert, L.; Serrano, C. Saavedra; Cortes, M. Gion; Sampaio-Alves, M.; Vitorino, M.; Pecen, L.; Singer, C.; Harbeck, N.; Rinnerthaler, G.; Greil, R.

研究方向

暂未获取到该数据
R
Richard Greil
H 指数:103论文数:1,406被引数:5.1万
S
Simon Peter Gampenrieder
H 指数:20论文数:139被引数:1,687
M
Marija Balić
H 指数:39论文数:317被引数:7,231
C
Christian F. Singer
H 指数:72论文数:693被引数:2.1万
D
Daniel Egle
H 指数:32论文数:258被引数:5,794
A
Andreas Petzer
H 指数:36论文数:230被引数:5,966
M
Michael Hubalek
H 指数:30论文数:183被引数:4,700
R
Rupert Bartsch
H 指数:53论文数:635被引数:1.1万
F
Florian Huemer
H 指数:19论文数:85被引数:4,442
J
Johannes Andel
H 指数:18论文数:124被引数:1,322